Hsbc Holdings PLC Has $200,000 Position in Quanterix Corporation $QTRX

Hsbc Holdings PLC boosted its position in shares of Quanterix Corporation (NASDAQ:QTRX) by 60.7% in the first quarter, according to the company in its most recent disclosure with the SEC. The firm owned 31,133 shares of the company’s stock after purchasing an additional 11,762 shares during the quarter. Hsbc Holdings PLC’s holdings in Quanterix were worth $200,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the company. Ameriprise Financial Inc. grew its holdings in Quanterix by 111.3% during the fourth quarter. Ameriprise Financial Inc. now owns 3,205,928 shares of the company’s stock valued at $34,079,000 after purchasing an additional 1,688,680 shares during the period. Millennium Management LLC grew its holdings in Quanterix by 6.0% during the fourth quarter. Millennium Management LLC now owns 2,185,101 shares of the company’s stock valued at $23,228,000 after purchasing an additional 122,969 shares during the period. Easterly Investment Partners LLC grew its holdings in Quanterix by 38.8% during the first quarter. Easterly Investment Partners LLC now owns 1,325,620 shares of the company’s stock valued at $8,630,000 after purchasing an additional 370,625 shares during the period. Dimensional Fund Advisors LP boosted its holdings in shares of Quanterix by 0.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 893,645 shares of the company’s stock valued at $9,500,000 after buying an additional 6,099 shares during the period. Finally, Russell Investments Group Ltd. boosted its holdings in shares of Quanterix by 51.1% in the first quarter. Russell Investments Group Ltd. now owns 606,787 shares of the company’s stock valued at $3,950,000 after buying an additional 205,311 shares during the period. Institutional investors and hedge funds own 86.48% of the company’s stock.

Insider Buying and Selling

In other Quanterix news, Director David R. Walt bought 123,990 shares of Quanterix stock in a transaction that occurred on Friday, June 13th. The stock was acquired at an average price of $6.14 per share, for a total transaction of $761,298.60. Following the completion of the acquisition, the director owned 1,866,933 shares of the company’s stock, valued at $11,462,968.62. This trade represents a 7.11% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders have acquired a total of 238,131 shares of company stock worth $1,402,860 in the last ninety days. Corporate insiders own 6.80% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on QTRX. Canaccord Genuity Group reiterated a “hold” rating and issued a $5.00 price target (down previously from $12.00) on shares of Quanterix in a report on Monday, August 11th. Wall Street Zen cut shares of Quanterix from a “hold” rating to a “sell” rating in a report on Thursday, May 22nd. One research analyst has rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $11.75.

Quanterix Trading Up 5.3%

Shares of QTRX opened at $4.55 on Friday. Quanterix Corporation has a 12 month low of $4.05 and a 12 month high of $15.85. The firm has a fifty day simple moving average of $5.44 and a 200 day simple moving average of $5.86. The stock has a market capitalization of $211.44 million, a price-to-earnings ratio of -2.50 and a beta of 1.03.

Quanterix (NASDAQ:QTRX) last announced its earnings results on Thursday, August 7th. The company reported ($0.47) EPS for the quarter, missing the consensus estimate of ($0.41) by ($0.06). Quanterix had a negative return on equity of 18.41% and a negative net margin of 56.04%.The business had revenue of $24.48 million for the quarter, compared to analyst estimates of $29.73 million. Quanterix has set its FY 2025 guidance at EPS. As a group, research analysts predict that Quanterix Corporation will post -0.98 earnings per share for the current fiscal year.

About Quanterix

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.